- Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001;344:1038-1042.
- Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001;344:1031-1037.
- O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T, Lechner K, Nielsen JL, Rousselot P, Reiffers J, Saglio G, Shepherd J, Simonsson B, Gratwohl A, Goldman JM, Kantarjian H, Taylor K, Verhoef G, Bolton AE, Capdeville R, Druker BJ, for the International Randomized Study of Interferon and STI571 Investigators. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003;348:994-1004.
- Lynch HT, Weisenburger D, Quinn-Laquer B, Watson P, Lynch J, Sanger W.
Hereditary Chronic Lymphocytic Leukemia: An extended Family Study and
Literature Review. Am Jour Med Genetics 2002;115:113-117. - Lynch H, Watson P, Tarantolo S, Wiernik P, Quinn-Laquer B, Bergsagel K, Huiart
H, Olopade O, Sobol H, Sanger W, Hogg D. Phenotypic Heterogeneity in Multiple
Myeloma Families. J Clin Onc 2005; 2005:23:685-693.